DCC protein as a predictor of distant metastases after curative surgery for rectal cancer

Diseases of the Colon and Rectum

Volumn 41, Issue 6, 1998, Pages 755-760

  Reymond, Marc A ^a   Dworak, Otto ^a   Remke, Stephan ^a   Hohenberger, Werner ^a   Kirchner, Thomas ^a   Köckerling, Ferdinand ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

DCC protein; Prognostic factors; Rectal neoplasms

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHROMOSOME 18Q; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; RECTUM CANCER; TUMOR SUPPRESSOR GENE;

CELL ADHESION MOLECULES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, CELL SURFACE; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0031806656     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02236264     Document Type: Article

References (24)

1. Hedrick L, Cho KR, Fearon ER, Wu TC, Kinzler KW, Vogeistein B. The DCC gene product in cellular differentiation, colorectal tumorigenesis. Genes Dev 1994;8: 1174-83.
2. Peinado MA, Malkhosyan S, Velasquez A, Perucho M. Isolation and characterization of allelic losses and amplifications in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc Natl Acad Sci U S A 1996;89:10065-9.
3. Tannapfel A, Köckerling F, Katalinic A, Wittekind C. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma [published erratum appears in Dis Colon Rectum 1995;38:802. Dis Colon Rectum 1995;38:651-4.
4. Cho KR, Vogelstein B. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence. J Cell Biochem Suppl 1992;16G:137-41.
5. Jiang WG, Puntis MC, Hallett MB. Molecular and cellular basis of cancer invasion and metastatic implications for treatment. Br J Surg 1994;81:1576-90.
6. Fearon ER, Cho KR, Nigro JM. Identification of a chromose 18q that is altered in colorectal cancer. Science 1990;247:49-56.
7. Klingelhutz AJ, Hedrick L, Cho KR, McDougall JK. The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 1995;10: 1581-6.
8. Jen J, Kim H, Piantadosi S. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.
9. Shibata D, Reale MA, Lavin P, et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med 1996; 335:1727-32.
10. Köckerling F, Reymond MA, Altendorf-Hofmann A, Hohenberger W. The influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 1998;16:324-9.
11. Sobin LH, Wittekind C (UICC), eds. TNM classification of malignant tumors. 5th ed. Baltimore: Wiley-Liss, 1997.
12. Umpleby HC, Bristol JB, Rainey JB, Williamson RC. Survival of 727 patients with single carcinomas of the large bowel. Dis Colon Rectum 1984;27:803-10.
13. Olson RM, Perencevich NP, Malcolm AW, Chaffey JT, Wilson RE. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer 1980;45:2969-74.
14. Gall FP, Hermanek P. Wandel und derzeitiger Stand der chirurgischen Behandlung des colorectalen Carcinoms. Chirurg 1992;63:227-34.
15. Pilipshen SJ, Heilweil M, Quan HQ, Sternberg SS, Enker WE. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 1984;53:1354-62.
16. Enker WE, Laffer UT, Block GE. Enhanced survival of patients with colon and rectal cancer is based upon wide anatomic resection. Ann Surg 1979;190:350-60.
17. Carlsson U, Lasson A, Ekelund G. Recurrence rates after curative surgery for rectal carcinoma, with special reference to their accuracy. Dis Colon Rectum 1987;30: 431-4.
18. McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AB. Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg 1985;72:34-7.
19. Philips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Local recurrence following "curative" surgery for large bowel cancer. I. The overall picture. Br J Surg 1984;761: 12-6.
20. Hermanek P, Wiebelt H, Staimmer D, Riedel St, for The German Study Group Colo-Rectal Carcinoma (SGCRC). Prognostic factors of rectum carcinoma: experience of the German Multicenter Study SGCRC. Tumori 1995; 81(Suppl 1):60-4.
21. Hohenberger, W. The effect of specialization or organization of rectal cancer surgery. In: Søreide O, ed. Rectal cancer surgery: optimization - standardisation -documentation. Heidelberg: Springer-Verlag, 1996.
22. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1: 1477-82.
23. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg 1982;82:613-6.
24. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264: 1444-50.